Omeros | Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Adma Biologics USD 75.63M 8.4M 2025-09
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Cytokinetics USD 1.94M 64.83M 2025-09
Dynavax Technologies USD 78.57M 24.17M 2025-06
Gilead Sciences USD 6.31B 106M 2025-12
Heron Therapeutics USD 23.35M 1.6M 2024-09
Immunic 0 0 2025-03
Insmed USD 111.44M 33.36M 2025-09
Knight Therapeutics CAD 44.83M 9.96M 2025-06
MacroGenics USD 61.25M 88.71M 2025-09
Omeros USD -33.16M 18.52M 2024-06
Pacira USD 130.92M 5M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Rockwell Medical USD 4.55M 1.49M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
United Therapeutics USD 602.1M 108.9M 2025-09
Vertex Pharmaceuticals USD 2.66B 104.4M 2025-09
Xoma 992K 846K 2024-06


Omeros Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.